As you may know, I was the founder and CEO of the Meridian Consulting Group. We had a retail consulting division and were responsible for projects like the “CVS store of the future” (CVS was the client, thank you Larry Zigarelli), or the reinvention of Walmart Skincare (special thanks to Pat Peters from Unilever, who […]

by

While glaucoma has been the butt of many well-intentioned, wink-wink weed jokes for decades, the disease is quit serious. In fact, glaucoma is the leading cause of blindness in people above sixty. Glaucoma is insidious as well. Abnormally high pressure in your eyes gradually damage the optic nerve. Vision loss is subtle until it reaches […]

by

The cannabidiol market place is likely to witness significant RD investment in the pharmaceutical industry as a broad-spectrum pharmaceutical therapeutics. Multiple scientific studies have shown promising results of cannabidiol for its potential in the treatment of a number of diseases. Following which the cannabidiol market is marked by a considerable cannabidiol therapeutics getting FDA approval or […]

by

NANAIMO, British Columbia–(BUSINESS WIRE)– NYU School of Medicine will lead trials testing CBD treatment for patients with Alcohol Use Disorder and Post-Traumatic Stress Disorder with Alcohol Use Disorder Tilray, Inc. (TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has received approval from the U.S. government and successfully imported an […]

by

Depth is all about discovering a new dimension. When you add width to length and height, you create volume, which just happens to be a synonym for “book.” I’ve just finished Eric Topol’s latest tome, “Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again,” and was fascinated by its multidimensional narrative. Although artificial intelligence […]

by

If spiders get high on marijuana, would the webs they weave become more intricate? More creative? More artistic? Or would it become a sloppy mess?     Believe it or not, scientists have been conducting studies on spiders and intoxicants dating back to 1948, when a German zoologist and a German pharmacologist teamed up to study […]

by

From Taiwanese cheese tea (tea topped with cheesy foam), which is apparently poised to become “the new bubble tea,” to a rise in “peganism” (a paleo/vegan diet mashup), forecasters have already predicted several new trends for 2019. But if there’s one thing Canadians can count on to radically transform food and drink in the new […]

by

ValueWalk’s interview with Whitt Steineker and Jay Wright, partners and co-leaders of Bradley’s Cannabis Industry team. In this interview, Whitt and Jay discuss the importance of the federal Controlled Substances Act, if medical marijuana is legal on a federal level, if Canadian marijuana businesses are safer than American marijuana investments, investment opportunities in hemp-derived CBD, […]

by

KEY POINTS A lack of evidence and formalized training means that physicians remain uncertain as to how cannabis can be used to treat medical conditions. The legalization of recreational cannabis and overwhelming marketing may have primed some patients to believe in its effectiveness for many indications. Self-styled medical and nonmedical experts project an image of […]

by

A phase 2 clinical trial has found a CBD capsule can reduce the frequency of seizures in children with epilepsy. Harvest One, through its subsidiary Satipharm has announced positive results with CBD Gelpell® capsules in the management of treatment resistant epilepsy (TRE). The results have been published in Epilepsy Behaviour, a bimonthly peer-reviewed medical journal […]

by

SAN FRANCISCO and TEL AVIV, Israel, Aug. 19, 2019 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera“) today announced that interim results from the Company’s Phase 2 clinical study evaluating cannabidiol (“CBD”) for the prevention of acute graft versus host disease (“GVHD”) are significantly positive, and, as […]

by

Depth is all about discovering a new dimension. When you add width to length and height, you create volume, which just happens to be a synonym for “book.” I’ve just finished Eric Topol’s latest tome, “Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again,” and was fascinated by its multidimensional narrative. Although artificial intelligence […]

by